OBJECTIVES: The purpose of this study was to identify genetic variants associated with severe coronary artery disease (CAD). METHODS AND RESULTS: We used 3 case-control studies of white subjects whose severity of CAD was assessed by angiography. The first 2 studies were used to generate hypotheses that were then tested in the third study. We tested 12,077 putative functional single nucleotide polymorphisms (SNPs) in Study 1 (781 cases, 603 controls) and identified 302 SNPs nominally associated with severe CAD. Testing these 302 SNPs in Study 2 (471 cases, 298 controls), we found 5 (in LPA, CALM1, HAP1, AP3B1, and ABCG2) were nominally associated with severe CAD and had the same risk alleles in both studies. We then tested these 5 SNPs in Study 3 (554 cases, 373 controls). We found 1 SNP that was associated with severe CAD: LPA I4399M (rs3798220). LPA encodes apolipoprotein(a), a component of lipoprotein(a). I4399M is located in the protease-like domain of apolipoprotein(a). Compared with noncarriers, carriers of the 4399M risk allele (2.7% of controls) had an adjusted odds ratio for severe CAD of 3.14 (confidence interval 1.51 to 6.56), and had 5-fold higher median plasma lipoprotein(a) levels (P=0.003). CONCLUSIONS: The LPA I4399M SNP is associated with severe CAD and plasma lipoprotein(a) levels.
OBJECTIVES: The purpose of this study was to identify genetic variants associated with severe coronary artery disease (CAD). METHODS AND RESULTS: We used 3 case-control studies of white subjects whose severity of CAD was assessed by angiography. The first 2 studies were used to generate hypotheses that were then tested in the third study. We tested 12,077 putative functional single nucleotide polymorphisms (SNPs) in Study 1 (781 cases, 603 controls) and identified 302 SNPs nominally associated with severe CAD. Testing these 302 SNPs in Study 2 (471 cases, 298 controls), we found 5 (in LPA, CALM1, HAP1, AP3B1, and ABCG2) were nominally associated with severe CAD and had the same risk alleles in both studies. We then tested these 5 SNPs in Study 3 (554 cases, 373 controls). We found 1 SNP that was associated with severe CAD: LPA I4399M (rs3798220). LPA encodes apolipoprotein(a), a component of lipoprotein(a). I4399M is located in the protease-like domain of apolipoprotein(a). Compared with noncarriers, carriers of the 4399M risk allele (2.7% of controls) had an adjusted odds ratio for severe CAD of 3.14 (confidence interval 1.51 to 6.56), and had 5-fold higher median plasma lipoprotein(a) levels (P=0.003). CONCLUSIONS: The LPA I4399M SNP is associated with severe CAD and plasma lipoprotein(a) levels.
Authors: Nastaran Faghihnia; Sotirios Tsimikas; Elizabeth R Miller; Joseph L Witztum; Ronald M Krauss Journal: J Lipid Res Date: 2010-08-16 Impact factor: 5.922
Authors: Euan A Ashley; Atul J Butte; Matthew T Wheeler; Rong Chen; Teri E Klein; Frederick E Dewey; Joel T Dudley; Kelly E Ormond; Aleksandra Pavlovic; Alexander A Morgan; Dmitry Pushkarev; Norma F Neff; Louanne Hudgins; Li Gong; Laura M Hodges; Dorit S Berlin; Caroline F Thorn; Katrin Sangkuhl; Joan M Hebert; Mark Woon; Hersh Sagreiya; Ryan Whaley; Joshua W Knowles; Michael F Chou; Joseph V Thakuria; Abraham M Rosenbaum; Alexander Wait Zaranek; George M Church; Henry T Greely; Stephen R Quake; Russ B Altman Journal: Lancet Date: 2010-05-01 Impact factor: 79.321
Authors: Mika Kivimäki; Costan G Magnussen; Markus Juonala; Mika Kähönen; Johannes Kettunen; Britt-Marie Loo; Terho Lehtimäki; Jorma Viikari; Olli T Raitakari Journal: Int J Epidemiol Date: 2010-11-14 Impact factor: 7.196
Authors: Stephen F Kingsmore; Ingrid E Lindquist; Joann Mudge; Damian D Gessler; William D Beavis Journal: Nat Rev Drug Discov Date: 2008-03 Impact factor: 84.694
Authors: Oddgeir L Holmen; He Zhang; Wei Zhou; Ellen Schmidt; Daniel H Hovelson; Arnulf Langhammer; Maja-Lisa Løchen; Santhi K Ganesh; Ellisiv B Mathiesen; Lars Vatten; Carl Platou; Tom Wilsgaard; Jin Chen; Frank Skorpen; Håvard Dalen; Michael Boehnke; Goncalo R Abecasis; Inger Njølstad; Kristian Hveem; Cristen J Willer Journal: Hum Mol Genet Date: 2014-04-12 Impact factor: 6.150
Authors: Sonia López; Alfonso Buil; Jordi Ordoñez; Juan Carlos Souto; Laura Almasy; Mark Lathrop; John Blangero; Francisco Blanco-Vaca; Jordi Fontcuberta; José Manuel Soria Journal: Eur J Hum Genet Date: 2008-06-18 Impact factor: 4.246
Authors: Sebastian Okser; Terho Lehtimäki; Laura L Elo; Nina Mononen; Nina Peltonen; Mika Kähönen; Markus Juonala; Yue-Mei Fan; Jussi A Hernesniemi; Tomi Laitinen; Leo-Pekka Lyytikäinen; Riikka Rontu; Carita Eklund; Nina Hutri-Kähönen; Leena Taittonen; Mikko Hurme; Jorma S A Viikari; Olli T Raitakari; Tero Aittokallio Journal: PLoS Genet Date: 2010-09-30 Impact factor: 5.917